Valuation: Life Science REIT plc

Market Cap 138M 188M 161M 151M 259M 17.98B 262M 1.78B 694M 9.03B 706M 690M 29.88B P/E 2023
-10.2x
P/E 2024 -9.5x
Enterprise Value 252M 344M 294M 276M 473M 32.89B 480M 3.26B 1.27B 16.52B 1.29B 1.26B 54.65B EV / Sales 2023
15.8x
EV / Sales 2024 12.2x
Free-Float
91.4%
Yield 2023
3.16%
Yield 2024 2.63%
6 months+1.41%
Current year+9.39%
Current year 34
Extreme 34
44.3
1 year 34
Extreme 34
44.3
3 years 31.3
Extreme 31.3
76.8
5 years 31.3
Extreme 31.3
106
10 years 31.3
Extreme 31.3
106
Manager TitleAgeSince
Chief Executive Officer - 2021-10-31
Director of Finance/CFO - 2021-10-31
Investor Relations Contact - 2023-03-31
Director TitleAgeSince
Chairman 58 2021-10-31
Director/Board Member 64 2021-10-13
Director/Board Member 65 2021-10-13
Date Insider Type Main position Quantity % Market Cap.
12/6/22 Buy

Director

30,000 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+6.42%+12.83%-28.64% 204M
+2.38%+6.65%-0.80%+5.46% 51.76B
+1.57%+3.58%+10.45%+23.42% 18.57B
+1.35%+2.80%-0.91%-9.17% 17.78B
+1.85%+1.64%-6.16%-6.91% 15.23B
+1.68%+1.76%-2.11%-1.01% 14.82B
+0.85%+1.88%+10.53%-1.93% 12.7B
+1.47%+3.60%-1.11%-1.44% 12.36B
+1.89%+3.25%-1.28%-0.70% 12.13B
+1.41%+0.54%-0.03%+2.08% 11.03B
Average +1.49%+0.22%+2.14%-1.88% 16.66B
Weighted average by Cap. +1.84%-0.04%+0.71%+2.40%

Financials

2023 2024
Net sales 19.94M 27.18M 23.28M 21.79M 37.43M 2.6B 37.92M 257M 100M 1.31B 102M 99.84M 4.32B 20.31M 27.68M 23.71M 22.19M 38.11M 2.65B 38.62M 262M 102M 1.33B 104M 102M 4.4B
Net income -21.71M -29.59M -25.34M -23.71M -40.74M -2.83B -41.27M -280M -109M -1.42B -111M -109M -4.7B -13.98M -19.05M -16.32M -15.27M -26.23M -1.82B -26.58M -180M -70.35M -916M -71.53M -69.98M -3.03B
Net Debt 93.58M 128M 109M 102M 176M 12.2B 178M 1.21B 471M 6.13B 479M 468M 20.28B 114M 156M 133M 125M 214M 14.9B 217M 1.48B 575M 7.49B 585M 572M 24.77B
Logo Life Science REIT plc
Life Science REIT Ltd, formerly Life Science REIT plc, is a closed-ended real estate investment trust. The Company’s investment objective is to provide shareholders with an attractive level of total return. It seeks to invest in a diversified portfolio of properties across the United Kingdom, which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. It acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The Company retains flexibility to acquire individual buildings, a group of buildings across a single science park or the entirety of a science park. It also includes purchasing or developing buildings that are leased or intended to be leased to occupiers, providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector.
Employees
-
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. LABS Stock